Skip to main content

Table 2 Association between LYRM4 protein expression and various clinicopathological factors in LIHC patients

From: Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma

Variables LYRM4 protein expression p value
Low (n = 43) High (n = 49)
Gender
 Male 36 41 0.9951
 Female 7 8  
History of drinking
 Yes 12 20 0.2226
 No 30 29  
Hepatitis B
 Yes 30 41 0.7605
 No 2 2  
History of smoking
 Yes 17 20 0.8363
 No 26 28  
Liver cirrhosis
 Yes 33 31 0.1610
 No 10 18  
History of Hepatitis
 Yes 28 34 0.6628
 No 15 15  
Grade (G)
 G1–G2 37 41 0.8785
 G3 5 5  
TNM stage
 I–II 31 33 0.6216
 III–IV 12 16  
Tumor thrombus
 Yes 11 15 0.5973
 No 31 33  
Tumor encapsulation
 Yes 6 4 0.2790
 No 31 43  
Tumor size 3.65 (2.2, 6.13) 3 (2.0, 5) 0.1850
Age 59 ± 10.9 55 ± 8.4 0.0410
ALB (g/L) 35.9 ± 5.1 37.1 ± 4.8 0.2240
LDL (mmol/L) 2.0 ± 0.7 2.3 ± 0.8 0.0340
AFP (ng/mL) 16.7 (3.9, 291.7) 32.2 (4.7, 388.3) 0.5340
TBIL (mmol/L) 13 (11, 21.5) 12 (10, 17) 0.4100
DBIL (mmol/L) 7 (5, 10.3) 6 (4.5, 9) 0.3030
IBIL (mmol/L) 6 (5, 10) 6 (5, 9) 0.6600
ALT (U/L) 53.5 (30.8, 116) 52 (36, 86.5) 0.8750
AST (U/L) 37.5 (27, 53.5) 34 (23.5, 57.5) 0.5650
ALP (U/L) 89.5 (73.8, 122.3) 94 (75.5, 118) 0.8600
TG (mmol/L) 0.9 (0.7, 1.1) 1.1 (0.9, 1.5) 0.0130
  1. The bold values indicate the significant difference between the two groups of data, and the statistical significance was set at p < 0.05